Our previous study has also indicated that the HPV16/18 E6 oncoprotein may contribute to EGFR mutations through inhibited hMLH1 and hMSH2 gene expression in Taiwanese lung cancer patients [30]. This evidence concerns the gene MSH2 and lung carcinoma.